Management of Post-Drug Nausea, Vomiting, and Rash
Immediately discontinue the offending drug and assess rash severity—mild rashes require symptomatic relief with antihistamines and corticosteroids, while Stevens-Johnson syndrome mandates cessation of ALL medications until resolution. 1
Immediate Assessment and Drug Discontinuation
Stop the causative medication immediately. 1 The presence of rash alongside nausea and vomiting suggests a hypersensitivity reaction rather than simple drug intolerance, requiring permanent discontinuation of the implicated agent. 1
Classify Rash Severity
- Mild reactions (localized erythema, limited pruritus): Proceed with symptomatic management while monitoring closely. 1
- Stevens-Johnson syndrome (widespread blistering, mucosal involvement, systemic symptoms): This is a medical emergency—stop ALL medications including any concurrent treatments until complete symptom resolution. 1
- Severe reactions with systemic symptoms (hypotension, dyspnea, tachycardia, widespread urticaria): Treat as anaphylaxis and never rechallenge with the implicated drug. 1
Acute Treatment Protocol
For Nausea and Vomiting Management
Start dopamine receptor antagonists as first-line therapy: 2, 3
- Metoclopramide 5-10 mg IV/PO every 6-8 hours (reduce dose by 25-50% in elderly patients) 2
- Haloperidol 0.5-2 mg IV/PO every 4-6 hours 2
If symptoms persist after 24 hours, add a 5-HT3 antagonist for synergistic effect: 3, 4
- Ondansetron 4-8 mg IV/PO 2-3 times daily 3, 4
- Monitor for QTc prolongation when using ondansetron, especially with other QT-prolonging medications 3
For Rash Management
Mild reactions: 1
- Diphenhydramine 25-50 mg IV/PO every 6 hours 5
- Methylprednisolone 100 mg IV or equivalent corticosteroid 5
- Combination antihistamine plus corticosteroid therapy provides optimal symptom control 5
Stevens-Johnson reactions: 1
- Cease ALL drugs immediately (including TB medications, antiretrovirals, and any other concurrent therapies) 1
- Provide supportive care until complete resolution 1
- Sequential reintroduction can occur only after full recovery, adding medications one at a time every 2 days while monitoring response 1
Route of Administration Considerations
When oral intake is compromised by active vomiting: 3
- Use IV or subcutaneous infusions for antiemetics 3
- Consider rectal suppositories or sublingual formulations as alternatives 3
Critical Pitfalls to Avoid
- Never attempt drug rechallenge during active rash—wait for complete resolution before considering sequential reintroduction. 1
- Never restart the infusion at a slower rate if the patient developed a full-body rash, as this represents a severe systemic reaction requiring permanent discontinuation. 5
- Do not use antiemetics if bowel obstruction is suspected, as this can mask progressive ileus. 3
- Monitor for extrapyramidal side effects with dopamine antagonists, particularly in young males and elderly patients. 2, 3
- Avoid long-term benzodiazepine use in elderly patients who may require anxiolytic therapy for nausea. 2
Special Population Adjustments
Elderly patients: 2
- Reduce initial antiemetic doses by 25-50% 2
- Start lorazepam at 0.25 mg (not 0.5-1 mg) if anxiolytic needed 2
- Monitor closely for extrapyramidal effects and sedation 2
Refractory Symptoms
If nausea and vomiting persist despite around-the-clock dopamine antagonist plus 5-HT3 antagonist: 3
- Add dexamethasone as third-line agent 3
- Consider continuous IV or subcutaneous antiemetic infusions 3
- Consult palliative care or allergy/immunology specialists for refractory cases 1, 3
Drug Rechallenge Protocol (Only After Complete Resolution)
If the implicated drug is essential and rash has completely resolved: 1
- Reintroduce medications sequentially, one at a time every 2 days 1
- Monitor closely for recurrence of rash or systemic symptoms 1
- If the patient had a very severe life-threatening reaction, the implicated drug should never be used again 1
- For moderate reactions involving blood pressure changes or respiratory symptoms, consult an allergist before any rechallenge attempt 1